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g.2012.1Abstract The aim of this work was to evaluate the efﬁcacy of Helium Neon (He–Ne) laser therapy
on post mastectomy lymphedema and shoulder mobility. Thirty female patients with axillary lymph
node dissection (ALND), with or without radiotherapy had been participated in this study. The
patients were randomly divided into two groups of equal numbers. Group A received He–Ne laser
therapy and decongestive lymphatic therapy. Group B received placebo laser therapy in addition to
decongestive lymphatic therapy. Measurements of limb volume and shoulder mobility (by tape
measurement and standard goniometer) were collected before treatment and after six months of
treatment. The mean values of limb volume and Shoulder mobility after 6 months of treatment
showed a signiﬁcant improvement (p< 0.05) for the two groups of the study with a greater
improvement for patients in group A.
Conclusion: Helium Neon laser therapy has a positive effect in reducing post mastectomy lymph-
edema and increasing range of motion of shoulder joint.
 2012 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Breast cancer is recognized as a major problem because of its
high incidence, mortality rate, and detrimental impact on the
quality of life. Carcinoma of the breast continues to be the
most common cancer in women over the age of 40 years,
and represents one of every seven new cancer cases diagnosed1001475828.
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1.003[1]. The women who had axillary lymph nodes dissection
(ALND) (secondary to breast cancer) as well as curative effect
of radiation and chemotherapy are at risk to develop lymphe-
dema and they have a prevalence of 25–30% [2].
Lymphedema is an accumulation of protein rich interstitial
ﬂuid because of impaired lymphatic function [3]. Lymphedema
can begin insidiously post mastectomy or several years later,
and swelling may range from being mild and barely noticeable
especially in the early stage to seriously disabling enlargement
[4]. In post mastectomy patients, chronic lymphedema has the
potential to become a permanent progressive condition. Al-
lowed to be progressing the condition can become extremely
treatment resistant and in most cases cannot be completely re-
lieved with either medical or surgical means [5].
Short-term complications such as increased fullness of soft tis-
sues, heaviness of the affected extremity, discomfort, and painier B.V. All rights reserved.
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shoulder mobility and decreased functional ability. The lymphe-
dema in turn may be subsequent to ﬁbrosis of the tissues because
of deposition of protein rich ﬂuids in interstitial tissues [4,6].
Treatment of lymphedema is difﬁcult and multidisciplinary
in nature, and even in the best outcome costly and time con-
suming. Therapy available for lymphedema may be divided
into three general categories, pharmacological, surgical and
rehabilitation. The later is a multidisciplinary and comprehen-
sive treatment approach incorporating specialized massage,
skin care, bandaging, exercises, and pneumatic pump and com-
plex decongestive therapy (CDT) [7].
Range of motion (ROM) restrictions of the ipsilateral arm
are almost universal and are the result of tissue manipulation
and positioning during surgery. Even if successful, resolution
of surgery-induced ROM restrictions occurs. Lymphedema, by
itself, can cause ROM limitations of the shoulder, elbow, and
wrist. As the expanding subcutaneous tissues reach maximum
capacity, tissue spaces that are necessary for free movement of
the joints become full of ﬂuid, and joint mobility can be severely
reduced. The sheer weight of the arm further limits movement,
can negatively alter posture, and can reduce the functional abil-
ities necessary for independent activities of daily living [8,9].
Low level laser therapy (LLLT) is reported to have beneﬁ-
cial effects on cells and tissues. These remarkable effects are re-
ported for treatment of a wide range of conditions (e.g.
musculoskeletal disorder, wound healing problem, scar and
pain). Laser was reported to have an efﬁcacy for treatment of
lymphedema [10,11]. Laser has been used for treatment of post
mastectomy lymphedema as it encourages lymphangiogenesis
and stimulation of lymphatic drainage as well as stimulation
of macrophage cells and stimulation of the immune system
[12].The current study had been conducted to determine the ef-
fect of Helium Neon laser therapy (which is a type of LLLT) in
the treatment of lymphedema and shoulder mobility.
2. Subjects and methods
Thirty female volunteer patients from the National Cancer
Institute who had modiﬁed radical mastectomy and had lymph-
edema of the upper limb secondary to breast cancer surgery
were included in the study. Their ages ranged from 45 to
55 years. They were examined carefully by the physician before
the study procedures. All patients were free from any other
pathological conditions or histories of other health abnormali-
ties except arm lymphedema. The patients were excluded if they
had recurrent malignancy, active infection, clinical evidence of
obstructive venous diseases, bilateral upper limb lymphedema,
neurological and orthopedic problems, or diabetes.
The patients were randomly assigned into two main groups
(A and B). Group A: (study group) included 15 patients who
received laser therapy (Helium Neon laser therapy) in addition
to decongestive lymphatic therapy. Group B: (Control group)
included 15 patients who received placebo laser therapy in
addition to decongestive lymphatic therapy. Treatment ses-
sions were conducted three times per week for 6 months.
2.1. Ethical consideration
The study protocol was explained in detail for each patient
before the initial assessment and signed informed consentwas obtained from each patient before enrollment in the
study.
2.2. Measurements
Primary clinical and laboratory investigations were done to
draw a complete picture of the health of all patients and to de-
cide if the patient is able to undergo the experiment. The pa-
tient’s name, age, weight and height, were written in the
evaluation sheet of every patient. The measurement procedures
were conducted before treatment application and at the end of
the study after 6 months.
2.3. Lymphedema volume measurement procedure
The patients were placed in the supine lying position on a
plinth with arm resting comfortably at the sides with forearm
in pronation. This position enables easy access to ulnar styloid
process for measurement. The limb was divided into intervals
of 10 cm from the ulnar styloid process and with total of four
segments. The distal and proximal circumferences for each seg-
ment were measured. The distance between the distal and
proximal circumferences was measured. The measurement
was calculated by using the following formula.
V ¼ L=12pðC21 þ C1C2þ C2Þ
where v= volume, C1 and C2 are the measured circumfer-
ences at the either end of the chosen segment of length (L), p
a constant of 3.12 [13].
2.4. Shoulder mobility measurement procedure
A standard goniometer was used to measure active ROM
for shoulder ﬂexion, abduction, and external rotation. For
measurement the patient was placed supine with the thorax
ﬁrmly strapped to the table to prevent body shift, which
would tend to compensate for movement of the shoulder
[14]. For shoulder, abduction and external rotation, the
range of motion measurement started from neutral zero po-
sition to the limit of pain. The patient is asked actively to
move the limb in the desired direction as she can till the
appearance of pain and the degree of joint movement was
recorded [15].
2.5. Laser treatment procedure
The laser unit was set at the following treatment parameters
(frequency: 5000 Hz, duration: 15 min, pulse duration: 50 ns,
power intensity: 5 mW, wave length: 632.8 nm and dosage:
1.5 J/cm2). The patients were placed in a comfortable supine
position. A plastic guide with a grid of 17 treatment points
centered at 2 cm interval, was placed in axilla to guide
application and determine the points of application for laser
therapy. During the laser treatment head was held in con-
tact with and at right angles to the skin, after that the ther-
apist presses on the emission enabling key to allow
irradiation beam passages through laser aperture. Each
point had been irradiated for one minute with a total dura-
tion of 17 min [6].
Table 2 Comparison of lymphedema volume (ml) pre and
post treatment in both groups.
Groups A B
Treatment Pre Post Pre Post
Mean 1245.66 960.46 1282.13 1124.00
SD ±101.36 ±76.00 ±97.43 ±121.99
t-Value 13.28 7.83
p-Value 0.00 0.00
Signiﬁcance Signiﬁcant Signiﬁcant
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Decongestive lymphatic therapy comprises a number of inter-
related treatment modalities that are most effective when uti-
lized in an interdependent fashion.
 Proper skin care will optimize the supple texture of the skin
and with the other components of this therapy and mini-
mize the risk of infection through cutaneous portals of
entry.
 Manual lymphatic therapy is a specialized form of massage
that has been demonstrated to stimulate and direct lympha-
tic ﬂow, thereby decreasing the edema and ﬁbrous changes
of the involved extremity.
 Application of multilayered low-stretch bandages (with
appropriate padding) is utilized to enhance the effect of
muscular activity upon the clearance of lymphatic ﬂuid
from the limb.
 Exercises include active range of motion, and they are max-
imally effective when performed while the edematous limb
is bandaged. Isometric exercise is of dubious beneﬁt and
may, in fact, promote worsening of the edema [16].Figure 1 Comparison of lymphedema volume (ml) pre and post
treatment in both groups.3. Data analysis
The equivalence of both groups was checked by conducting
independent t-test on lymphedema volume and shoulder
mobility. Paired t-test was calculated on the pretest to posttest
change within each group. Finally to assess whether any differ-
ence existed in the posttest scores, an independent t-test was
calculated on the posttest change for both groups. The level
of signiﬁcance p< 0.05 was used.
4. Results
The descriptive characteristics of both groups are shown in Ta-
ble 1. There were no statistical differences between both groups
regarding the age and lymphedema period.
4.1. Comparison between pre and post treatment within the same
group
4.1.1. Results of lymphedema volume
The mean value of lymphedema volume pretreatment in the
group A was 1245.66 ± 101.3 ml. and the value after treat-
ment was 960.46 ± 76.00 ml. The paired t-test demonstrated
a statistically signiﬁcant difference between pre and post treat-
ment for lymphedema volume in this group (t= 13.28,
p= 0.00).Table 1 Descriptive statistics in both groups.
Comparison Age (years) Lymphedema period (months)
Groups A B A B
Mean 49.13 48.66 19.80 18.66
SD ±2.58 ±2.31 ±4.31 ±2.84
t-Value 0.520 0.850
p-Value 0.607 0.403
Signiﬁcance Not signiﬁcant Not signiﬁcantThe mean value of lymphedema volume pretreatment in the
group B was 1282.13 ± 97.43 ml. and the value after treatment
was 1124.00 ± 121.99 ml. The paired t-test demonstrated a
statistically signiﬁcant difference between pretest and posttest
for lymphedema volume in this group (t= 7.83, p= 0.00),
Table 2, Fig. 1.
4.1.2. Results of shoulder mobility
The paired t-test showed a signiﬁcant increase in range of mo-
tion in both groups regarding shoulder ﬂexion, abduction and
external rotation in comparing pre and post treatment range of
motion scores with (p< 0.05), Tables 3 and 4.
4.2. Comparison between both groups at the end of treatment
4.2.1. Results of lymphedema volume
Independent t-test showed a signiﬁcant decrease in lymphe-
dema volume after 6 months of treatment in group A in rela-
tion to group B (p= 0.00), Table 5 and Fig. 2.
4.2.2. Results of shoulder mobility
Independent t-test showed a signiﬁcant increase in shoulder
mobility (ﬂexion, abduction and external rotation) after
6 months of treatment in group A in relation to group B
(p= 0.00) as shown in Table 6.
5. Discussion
This study demonstrated that, laser therapy was signiﬁcantly
more effective in reducing limb volume and increasing shoul-
der mobility associated with post mastectomy lymphedema.
Table 3 Comparison between shoulder mobility (in degrees) pre and post treatment in group A.
Shoulder ROM Flexion Abduction External rotation
Treatment Pre Post Pre Post Pre Post
Mean 151.40 173.20 162.28 172.40 70.38 81.90
SD ±4.01 ±4.06 ±6.50 ±7.00 ±4.18 ±4.31
t-Value 25.63 12.49 38.25
p-Value 0.00 0.00 0.00
Level of signiﬁcance Signiﬁcant Signiﬁcant Signiﬁcant
Table 6 Comparison of shoulder mobility (in degrees) after end of
Shoulder ROM Flexion
Groups A B
Mean 173.20 163.93
SD ±4.06 ±7.15
t-Value 4.10
p-Value 0.00
Level of signiﬁcance Signiﬁcant
Table 4 Comparison between shoulder mobility (in degrees) pre and post treatment in group B.
Shoulder ROM Flexion Abduction External rotation
Treatment Pre Post Pre Post Pre Post
Mean 150.16 163.93 158.36 163.40 70.38 75.60
SD ±5.70 ±7.15 ±5.92 ±5.32 ±4.23 ±4.10
t-Value 8.31 6.64 15.69
p-Value 0.00 0.00 0.00
Level of signiﬁcance Signiﬁcant Signiﬁcant Signiﬁcant
Figure 2 Comparison of lymphedema volume between both
groups after end of treatment.
Table 5 Comparison of lymphedema volume (ml) after end of
treatment.
Groups A B
Mean 960.46 1124.00
SD ±76.00 ±121.99
t-Value 4.156
p-Value 0.00
Level of signiﬁcance Signiﬁcant
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ied the effect of laser therapy in post mastectomy arms lymph-
edema (duration >4 years). This trial found that the arms
responded well to the laser therapy. There was a reduction in
the amount of edema and volume of the extracellular ﬂuid as
measured by bioimpedence. The tissues become softer as
measured by tonometry and the patients perceived an improve-
ment in symptoms of pain, tightness, heaviness, and cramps as
well as mobility of the limb. The arm had lost 19.7% of its
edema volume during the ﬁrst 16 sessions, in addition to 7%
loss over 6 months.
Similarly, Thelnder [17], examined the effect of low level
laser therapy (LLLT) (wavelength of 632.8 nm, output
intensity of 9 mW, and energy density of 2.4 J/cm2) on lymphe-
dema. The laser therapy targets the areas of blockage of ﬁbrosis
starting over the chest wall and axilla and moving distally in the
arm. Results conﬁrmed that the patients treated with laser ther-
apy had a signiﬁcant reduction of the lymphedema and drop in
the rate of infections. Also they reported a signiﬁcant reduction
of lymphedema of the face and neck following surgery and asso-
ciated radiotherapy for cancer of thyroid.
The effect of LLLT may be due to, restoration of lymphatic
drainage through the axillary regions due to stimulation of
new lymphatic pathways and restoration of draining through
reduction of ﬁbrosis and scaring of tissues as there was evi-
dence of tissue softening after treatment with LLLT [6].
Nussbaum [18] demonstrated that LLLT increased endo-
thelial prostacyclin secretion and degradation of ﬁbrin net-treatment between both groups.
Abduction External rotation
A B A B
172.40 163.40 81.90 75.60
±7.00 ±5.32 ±4.31 ±4.10
4.46 4.19
0.00 0.00
Signiﬁcant Signiﬁcant
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tion, LLLT increases the production of vascular endothelial
growth factors (VEGF) by smooth muscle cell ﬁbroblasts
and stimulation of endothelial cell growth thus enhancing vas-
cular and lymphatic repair and promotion of collateral growth
of lymphatic vessels.
Improved circulation due to LLLT irradiation is considered
to be one of the possible mechanisms of clinical effectiveness of
LLLT for the treatment of pain and edema reduction. The
reduction in tissue ﬂuid accumulation occurs through changes
in the blood ﬂow directly via effect on blood vessels (enhancing
vascular and lymphatic repair and promotion of collateral
growth of lymphatic vessels) or by neural or hormonal regula-
tions of vessels in the limb. The LLLT is capable of inducing
potent arteriolar vasodilatation and a consequent increase of
blood ﬂow [19]. The increased blood ﬂow occurs in two phases;
the ﬁrst increase occurred shortly after the laser irradiation
and the second additional increase occurred approximately
20 min after the irradiation. The sympathetic vasomotor nerve
plays a key role in the control mechanisms for arteriolar con-
striction. It is known that LLLT attenuates neural conduction
in the dorsal root of sensory nerves. Thus, it is reasonable to
hypothesize that the attenuation of the vasomotor nerve activ-
ity by laser would be involved in the LLLT induced arteriolar
vasodilatation [20].
In conclusion, we found that, a combination of laser ther-
apy and decongestive lymphatic therapy had a signiﬁcant ef-
fect on lymphedema reduction and increasing shoulder
mobility. For this, a program of laser therapy and deconges-
tive lymphatic therapy should form a core for most patients
with lymphedema aiming to reduce limb volume and improve
shoulder mobility.
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